Table Of Content

JOURNAL OF CHROMATOGRAPHY Author Index Abe, A., see Yamane, M. 568(1991)11 Brunner, L. A. and Luders, R. C. Allievi, C., Dostert, P. and Strolin Benedetti, M. Determination of a potential anxiolytic drug Determination of free salsolinol (CGS 20625) in human plasma by high- concentrations in human urine using gas performance liquid chromatography chromatography—mass spectrometry 568(1991)487 568(1991)271 Cardot, P. J. P., Gerota, J. and Martin, M. Altieri, I., see Pichini, S. 568(1991)267 Separation of living red blood cells by Aoyama, H., see Komatsu, S. 568(1991)460 gravitational field-flow fractionation Armando, I., Grossman, E., Hoffman, A. and 568(1991)93 Goldstein, D. S. Carlsten, J., see L6nnroth, P. 568(1991)419 Method for measuring endogenous 3-O- Celardo, A., Dell’Elba, G., Frassanito, R., methyldopa in urine and plasma Benfenati, E, and Bonati, M. 568(1991)45 Simultaneous determination of isbufylline Asano, T., see Miwa, H. 568(1991)25 and its major metabolites in rabbit blood Auriola, S., see Pennanen, S. 568(1991)125 and urine by reversed-phase high- Banno, K., Horimoto, S. and Mabuchi, M. performance liquid chromatography Assay of nicergoline and three metabolites in 568(1991)407 human plasma and urine by high- Chan, E. C. S., Siboo, I. R. and Siboo, R. performance liquid chromatography— Purification of phospholipase C by atmospheric pressure ionization mass hydrophobic interaction affinity spectrometry 568(1991)375 chromatography 568(1991)85 Barthomeuf, C., Pourrat, H. and Regerat, F. Chrisley, B. Mc., see Driskell, J. A. Densitometry for analysis of protein and 568(1991)333 peptide hydrolysates: application to Christensen, R. G., see Brown-Thomas, J. M. luteinizing hormone releasing hormone 568(1991)232 568(1991)451 Cohen, A. I., see Whigan, D. B. 568(1991)385 Bauer, W., see B6cker, R. H. 568(1991)363 Cook, J. A., see Skee, D. M. 568(1991)494 Belpaire, F. M., see Rosseel, M. T. 568(1991)239 Cox, S. R., see Schmith, V. D. 568(1991)253 Benfenati, E., see Celardo, A. 568(1991)407 Cypess, A. M., see Lloyd, D. K. 568(1991)117 Benziger, D. P., see Skee, D. M. 568(1991)494 Dalet-Fumeron, V., Guinec, N. and Pagano, M. Bertini, J., see Triolo, A. 568(1991)281 High-performance liquid chromatographic Beschke, K., see Greischel, A. 568(1991)246 method for the simultaneous purification of Bleiberg, B., Steinberg, J. J., Katz, S. D., Wexler, cathepsins B, H and L from human liver J. and LeJemtel, T. 568(1991)55 Determination of plasma lactic acid Degen, P., see Flesch, G. 568(1991)261 concentration and specific activity using Dell’ Elba, G., see Celardo, A. 568(1991)407 high-performance liquid chromatography Deyl, Z. 568(1991)301 High-performance liquid chromatography in Bocker, R. H., Peter, R., Machbert, G. and biotechnology (edited by W. S. Hancock) Bauer, W. (Book Review) 568(1991)501 Identification and determination of the two Dolphin, P. J., see Zhou, G. 568(1991)69 principal metabolites of minocycline in Dostert, P., see Allievi, C. 568(1991)271 humans 568(1991)363 Driskell, J. A., Chrisley, B. Mc., Reynolds, L. K. Bonati, M., see Celardo, A. 568(1991)407 and Moak, S. W. Boobis, A. R., see Murray, S. 568(1991)341 Plasma B, vitamer and plasma and urinary Brown, J., see Nijjar, M.S. 568(1991)393 4-pyridoxic acid concentrations of middle- Brown-Thomas, J. M., Christensen, R. G., aged obese black women 568(1991)333 Rieger, R., Malone, W. and May, W. E. Ellis, P. P., see Riegel, M. R. 568(1991)467 Determination of glycyrrhetinic acid in human plasma by high-performance liquid chromatography 568(1991)232 Brune, K., see Geisslinger, G. 568(1991)165 510 AUTHOR INDEX Eto, S., Noda, H. and Noda, A. Ivanov, A., see Kostadinova, S. 568(1991)315 High-performance liquid chromatographic Jamali, F., see Palylyk, E. L. 568(1991)187 method for direct separation of 5-(p- Jang, Y., see Singh, A. K. 568(1991)351 hydroxyphenyl)-5-phenylhydantoin Jauhiainen, M., see Zhou, G. 568(1991)69 enantiomers using a chiral tris(4- Johnson, L., see Loénnroth, P. 568(1991)419 methylbenzoate) column 568(1991)157 Kamberov, E., see Kostadinova, S. Fayer, B. E., Huselton, C. A., Garland, W. A. 568(1991)315 and Liberato, D. J. Kamp, H.-D., see Geisslinger, G. 568(1991)165 Quantification of acitretin in human plasma Katoh, T., see Ohba, S. 568(1991)325 by microbore liquid chromatography— Katz, S. D., see Bleiberg, B. 568(1991)301 negative chemical ionization mass Kawahara, Y., see Shioya, H. 568(1991)309 spectrometry 568(1991)135 Kenney, M. E., see Zuk, M. M. 568(1991)437 Flesch, G., Tominaga, N. and Degen, P. Kibe, T., see Ohba, S. 568(1991)325 Improved determination of the Kidouchi, K., see Ohba, S. 568(1991)325 bisphosphonate pamidronate disodium in Kinoshita, T., see Yokoyama, T. 568(1991)212 plasma and urine by pre-column Kissinger, P. T. derivatization with fluorescamine, high- Electroanalysis of biologically important performance liquid chromatography and compounds (by J. P. Hart) (Book Review) fluorescence detection 568(1991)261 568(1991)270 Frassanito, R., see Celardo, A. 568(1991)407 Kobayashi, M., see Ohba, S. 568(1991)325 Fujita, Y., see Watanabe, H. 568(1991)445 Kodama, H., see Watanabe, H. 568(1991)445 Garland, W. A., see Fayer, B. E. 568(1991)135 Komatsu, S., Murata, S., Aoyama, H., Zenki, T., Geisslinger, G., Menzel-Soglowek, S., Kamp, Ozawa, N., Tateishi, M. and Vrbanac, J. J. H.-D. and Brune, K. Micro-quantitative determination of Stereoselective high-performance liquid ciprostene in plasma by gas chromatographic determination of the chromatography—mass spectrometry coupled enantiomers of ketamine and norketamine in with an antibody extraction 568(1991)460 plasma 568(1991)165 Komulainen, H., see Pennanen, S. 568(1991)125 Gerota, J., see Cardot, P. J. P. 568(1991)93 Kostadinova, S., Ivanov, A. and Kamberov, E. Goldstein, D. S., see Armando, I. 568(1991)45 Purification and some properties of Granley, K., see Singh, A. K. 568(1991)351 phospholipase C from Achromobacter Granneman, G. R. and Varga, L. L. xylosoxidans 568(1991)315 High-performance liquid chromatographic Kotagal, U. R., see Tan, H. S. I. 568(1991)145 procedures for the determination of Kreimer-Birnbaum, M., see Zuk, M. M. temafloxacin in biological matrices 568(1991)437 568(1991)197 Kroboth, P. D., see Schmith, V. D. Greischel, A., Beschke, K., Rapp, H. and Roth, 568(1991)253 W. Kunsman, C. M., see Kunsman, G. W. Quantitation of the new hypoglycaemic 568(1991)427 agent AG-EE 388 ZW in human plasma by Kunsman, G. W., Manno, J. E., Przekop, M. A., automated high-performance liquid Manno, B. R., Llorens, K. A. and chromatography with electrochemical Kunsman, C. M. detection 568(1991)246 Determination of temazepam and Grimmelt, B., see Nijjar, M.S. 568(1991)393 temazepam glucuronide by reversed-phase Grossman, E., see Armando, I. 568(1991)45 high-performance liquid chromatography Guinec, N., see Dalet-Fumeron, V. 568(1991)55 568(1991)427 Hahn, M.-K., see Tan, H. S. I. 568(1991)145 LeJemtel, T., see Bleiberg, B. 568(1991)301 Hayashi, N., see Noma, J. 568(1991)35 Liberato, D. J., see Fayer, B. E. 568(1991)135 Himmel, H. M., Sadony, V. and Ravens, U. Llorens, K. A., see Kunsman, G. W. Quantitation of hypoxanthine in plasma 568(1991)427 from patients with ischemic heart disease: Lloyd, D. K., Cypess, A.M . and Wainer, I. W. adaption of a high-performance liquid Determination of cytosine-f-D-arabinoside in chromatographic method 568(1991)105 plasma using capillary electrophoresis Hoffman, A., see Armando, I. 568(1991)45 568(1991)117 Horimoto, S., see Banno, K. 568(1991)375 Huselton, C. A., see Fayer, B. E. 568(1991)135 Inoue, K., see Watanabe, H. 568(1991)445 AUTHOR INDEX Lonnroth, P., Carlsten, J., Johnson, L. and Noda, A., see Eto, S. 568(1991)157 Smith, U. Noda, H., see Eto, S. 568(1991)157 Measurements by microdialysis of free tissue Noma, J., Hayashi, N. and Sekiba, K. concentrations of propranolol 568(1991)419 Automated direct high-performance liquid Luders, R. C., see Brunner, L. A. 568(1991)487 chromatographic assay for estetrol, estriol, Mabuchi, M., see Banno, K. 568(1991)375 cortisone and cortisol in serum and amniotic Machbert, G., see B6cker, R. H. 568(1991)363 fluid 568(1991)35 Malone, W., see Brown-Thomas, J. M. Nordholm, L. 568(1991)232 Determination of the neuroprotective agent Manninen, A., see Pennanen, S. 568(1991)125 6-nitro-7-sulphamoylbenzo[/]quinoxaline-2,3- Manning, M. A., see Tan, H. S. 1. 568(1991)145 dione in plasma using high-performance Manno, B. R., see Kunsman, G. W. liquid chromatography 568(1991)481 568(1991)427 Novak, M., see Mare, P. 568(1991)1 Manno, J. E., see Kunsman, G. W. Offermanns, J., see Thurl, S. 568(1991)291 568(1991)427 Ohba, S., Kidouchi, K., Katoh, T., Kibe, T., Mannucci, C., see Triolo, A. 568(1991)281 Kobayashi, M. and Wada, Y. Mare, P., Rezanka, T. and Novak, M. Automated determination of orotic acid, Analysis of human blood plasma uracil and pseudouridine in urine by high- triacylglycerols using capillary gas performance liquid chromatography with chromatography, silver ion thin-layer column switching 568(1991)325 chromatographic fractionation and Ozawa, N., see Komatsu, S. 568(1991)460 desorption chemical ionization mass Pacifici, R., see Pichini, S. 568(1991)267 spectrometry 568(1991)1 Pagano, M., see Dalet-Fumeron, V. 568(1991)55 Martin, J. and White, I. N. H. Palylyk, E. L. and Jamali, F. Fluorimetric determination of oxidised and Simultaneous determination of ketoprofen reduced glutathione in cells and tissues by enantiomers and probenecid in plasma and high-performance liquid chromatography urine by high-performance liquid following derivatization with dansyl chromatography 568(1991)187 chloride 568(1991)219 Pennanen, S., Auriola, S., Manninen, A. and Martin, M., see Cardot, P. J. P. 568(1991)93 Komulainen, H. May, W. E., see Brown-Thomas, J. M. Identification of the main metabolites of 568(1991)232 2-ethylhexanoic acid in rat urine using gas McClain, C. J., see Schmidt, J. 568(1991)207 chromatography—mass spectrometry Menzel-Soglowek, S., see Geisslinger, G. 568(1991)125 568(1991)165 Perico, A., see Triolo, A. 568(1991)281 Mishra, U., see Singh, A. K. 568(1991)351 Pesonen, K. Miwa, H., Yamamoto, M. and Asano, T. Variation of hydrophobicity of human High-performance liquid chromatographic urinary epidermal growth factor analysis of fatty acid compositions of 568(1991)226 platelet phospholipids as their Pestellini, V., see Triolo, A. 568(1991)281 2-nitrophenylhydrazides 568(1991)25 Peter, R., see B6cker, R. H. 568(1991)363 Moak, S. W., see Driskell, J. A. 568(1991)333 Pichini, S., Altieri, I., Pacifici, R., Rosa, M. and Moncrieff, J. Zuccaro, P. Determination of theophylline in serum and Elimination of caffeine interference in high- saliva in the presence of caffeine and its performance liquid chromatographic metabolites 568(1991)177 determination of cotinine in human plasma Miiller-Werner, B., see Thurl, S. 568(1991)291 568(1991)267 Murata, S., see Komatsu, S. 568(1991)460 Pourrat, H., see Barthomeuf, C. 568(1991)451 Murray, S. and Boobis, A. R. Przekop, M. A., see Kunsman, G. W. Combined assay for phenacetin and 568(1991)427 paracetamol in plasma using capillary Rapp, H., see Greischel, A. 568(1991)246 column gas chromatography—negative-ion Ravens, U., see Himmel, H. M. 568(1991)105 mass spectrometry 568(1991)341 Regerat, F., see Barthomeuf, C. 568(1991)451 Nijjar, M. S., Grimmelt, B. and Brown, J. Reynolds, L. K., see Driskell, J. A. 568(1991)333 Purification of domoic acid from toxic blue Rezanka, T., see Mare’, P. 568(1991)1 mussels (Mytilus edulis) and phytoplankton 568(1991)393 AUTHOR INDEX 512 Riegel, M. R. and Ellis, P. P. Stevenson, K., see Zhou, G. 568(1991)69 Determination of trifluorothymidine in the Stopher, D. A., see Walker, D. K. 568(1991)475 eye using high-performance liquid Strolin Benedetti, M., see Allievi, C. chromatography 568(1991)467 568(1991)271 Rieger, R., see Brown-Thomas, J. M. Sugahara, K., see Watanabe, H. 568(1991)445 568(1991)232 Tan, H. G. H., see Tan, H. S. I. 568(1991)145 Rihter, B. D., see Zuk, M. M. 568(1991)437 Tan, H. S. I., Manning, M. A., Hahn, M.-K., Rodgers, M. A. J., see Zuk, M. M. 568(1991)437 Tan, H. G. H. and Kotagal, U. R. Rosa, M., see Pichini, S. 568(1991)267 Determination of benzyl alcohol and its Rosseel, M. T., Vermeulen, A. M. and Belpaire, metabolite in plasma by reversed-phase F. M. high-performance liquid chromatography Reversed-phase high-performance liquid 568(1991)145 chromatographic analysis of atenolol Tateishi, M., see Komatsu, S. 568(1991)460 enantiomers in plasma after chiral Thurl, S., Offermanns, J., Miller-Werner, B. and derivatization with (+ )-1-(9-fluorenyl)ethyl Sawatzki, G. chloroformate 568(1991)239 Determination of neutral oligosaccharide Roth, W., see Greischel, A. 568(1991)246 fractions from human milk by gel Sadony, V., see Himmel, H. M. 568(1991)105 permeation chromatography 568(1991)291 Sawatzki, G., see Thurl, S. 568(1991)291 Tominaga, N., see Flesch, G. 568(1991)261 Schmidt, J. and McClain, C. J. Triolo, A., Bertini, J.. Mannucci, C., Perico, A. Separation of o-phthalaldehyde— and Pestellini, V. mercaptoethanol derivatives of amino acids Analysis of platelet-activating factor by gas from blood plasma on reversed-phase Nova- chromatography—mass spectrometry: low- Pak C,, cartridges 568(1991)207 energy electron impact of the corresponding Schmith, V. D., Cox, S. R., Zemaitis, M. A. and 3-acetyl-2-tert.-butyldimethylsilyl derivative Kroboth, P. D. 568(1991)281 New high-performance liquid Varga, L. L., see Granneman, G. R. chromatographic method for the 568(1991)197 determination of alprazolam and its Vermeulen, A. M., see Rosseel, M. T. metabolites in serum: instability of 4- 568(1991)239 hydroxyalprazolam 568(1991)253 Vrbanac, J. J., see Komatsu, S. 568(1991)460 Sekiba, K., see Noma, J. 568(1991)35 Wada, Y., see Ohba, S. 568(1991)325 Shimojo, M., see Shioya, H. 568(1991)309 Wainer, I. W., see Lloyd, D. K. 568(1991)117 Shioya, H., Shimojo, M. and Kawahara, Y. Walker, D. K., Smith, D. A. and Stopher, D. A. Determination in plasma of angiotensin- Liquid-—liquid extraction and high- converting enzyme inhibitor by inhibitor- performance liquid chromatography for the binding assay 568(1991)309 determination of a novel antidysrhythmic Siboo, I. R., see Chan, E. C. S. 568(1991)85 agent (UK-68,798) in human urine Siboo, R., see Chan, E. C. S. 568(1991)85 568(1991)475 Singh, A. K., Jang, Y., Mishra, U. and Granley, Watanabe, H., Sugahara, K., Inoue, K., Fujita, K. Y. and Kodama, H. Simultaneous analysis of flunixin, naproxen, Liquid chromatographic—mass spectrometric ethacrynic acid, indomethacin, analysis for screening of patients with phenylbutazone, mefenamic acid and cystinuria, and identification of cystine thiosalicylic acid in plasma and urine by stone 568(1991)445 high-performance liquid chromatography Wexler, J., see Bleiberg, B. 568(1991)301 and gas chromatography—mass Whigan, D. B. and Cohen, A. I. spectrometry 568(1991)351 High-performance liquid chromatographic Skee, D. M., Cook, J. A. and Benziger, D. P. determination of 1-f-b-arabinofuranosyl- Determination of a novel steroidal androgen E-5-(2-bromovinyl)uracil and its metabolite receptor antagonist (Win 49596) in human (£)-5-(2-bromovinyl)uracil in serum plasma using solid-phase extraction and 568(1991)385 high-performance liquid chromatography White, I. N. H., see Martin, J. 568(1991)219 with ultraviolet detection 568(1991)494 Yamamoto, M., see Miwa, H. 568(1991)25 Smith, D. A., see Walker, D. K. 568(1991)475 Smith, U., see Lonnroth, P. 568(1991)419 Steinberg, J. J., see Bleiberg, B. 568(1991)301 AUTHOR INDEX Yamane, M. and Abe, A. Zhou, G., Jauhiainen, M., Stevenson, K. and High-performance liquid chromatography— Dolphin, P. J. thermospray mass spectrometry of Human plasma lecithin:cholesterol prostaglandin and thromboxane acetyl acyltransferase. Preparation and use of derivatives 568(1991)11 immobilized p-aminophenylarsenoxide as a Yokoyama, T. and Kinoshita, T. catalytic site-directed covalent ligand in High-performance liquid chromatographic enzyme purification 568(1991)69 determination of taurine in biological fluids Zuccaro, P., see Pichini, S. 568(1991)267 by post-column fluorescence reaction with Zuk, M. M., Rihter, B. D., Kenney, M. E., thiamine 568(1991)212 Rodgers, M. A. J. and Kreimer-Birnbaum, Zemaitis, M. A., see Schmith, V. D. M. 568(1991)253 Photosensitizers for tumor therapy: Zenki, T., see Komatsu, S. 568(1991)460 determination of bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC) in rat tissue and serum by high-performance liquid chromatography 568(1991)437 JOURNAL OF CHROMATOGRAPHY Compound Index Acitretin Arginine Quantification of acitretin in human plasma by Liquid chromatographic—mass spectrometric microbore liquid chromatography-—negative analysis for screening of patients with cystinuria, chemical ionization mass spectrometry and identification of cystine stone 568(1991)445 568(1991)135 Atenolol AG-EE 388 ZW Reversed-phase high-performance liquid Quantitation of the new hypoglycaemic agent chromatographic analysis of atenolol enantiomers AG-EE 388 ZW in human plasma by automated in plasma after chiral derivatization with (+ )-1- high-performance liquid chromatography with (9-fluorenyl)ethyl chloroformate 568(1991)239 electrochemical detection 568(1991)246 Benzaldehyde Alprazolam Determination of benzyl alcohol and its New high-performance liquid chromatographic metabolite in plasma by reversed-phase high- method for the determination of alprazolam and performance liquid chromatography its metabolites in serum: instability of 4- 568(1991)145 hydroxyalprazolam 568(1991)253 Benzocaine Amino acids Determination of benzyl alcohol and its Separation of o-phthalaldehyde—mercaptoethanol metabolite in plasma by reversed-phase high- derivatives of amino acids from blood plasma on performance liquid chromatography reversed-phase Nova-Pak C,, cartridges 568(1991)145 568(1991)207 Benzoic acid Liquid chromatographic—mass spectrometric Determination of benzyl alcohol and its analysis for screening of patients with cystinuria, metabolite in plasma by reversed-phase high- and identification of cystine stone 568(1991)445 performance liquid chromatography 568(1991)145 Densitometry for analysis of protein and peptide hydrolysates: application to luteinizing hormone Benzyl alcohol releasing hormone 568(1991)451 Determination of benzyl alcohol and its metabolite in plasma by reversed-phase high- p-Aminophenylarsenoxide performance liquid chromatography Human plasma lecithin:cholesterol 568(1991)145 acyltransferase. Preparation and use of immobilized p-aminophenylarsenoxide as a Bis(di-isobuty! octadecylsiloxy)silicon 2,3- catalytic site-directed covalent ligand in enzyme naphthalocyanine purification 568(1991)69 Photosensitizers for tumor therapy: determination of, bis(di-isobutyl octadecylsiloxy)silicon 2,3- Angiotensin-converting enzyme inhibitor naphthalocyanine (isoBOSINC) in rat tissue and Determination in plasma of angiotensin- serum by high-performance liquid converting enzyme inhibitor by inhibitor-binding chromatography 568(1991)437 assay 568(1991)309 (£)-5-(2-Bromovinyl)uracil 1-6-p-Arabinofuranosyl- E-5-(2-bromoviny])uracil High-performance liquid chromatographic High-performance liquid chromatographic determination of 1-f-p-arabinofuranosyl-E-5-(2- determination of 1-f-p-arabinofuranosyl-E-5-(2- bromovinyl)uracil and its metabolite (£)-5-(2- bromovinyl)uracil and its metabolite (£)-5-(2- bromovinyl)uracil in serum 568(1991)385 bromovinyl)uracil in serum 568(1991)385 COMPOUND INDEX Caffeine Domoic acid Elimination of caffeine interference in high- Purification of domoic acid from toxic blue performance liquid chromatographic mussels (Mytilus edulis) and phytoplankton determination of cotinine in human plasma 568(1991)393 568(1991)267 L-DOPA Cathepsins Method for measuring endogenous 3-O- High-performance liquid chromatographic methyldopa in urine and plasma 568(1991)45 method for the simultaneous purification of cathepsins B, H and L from human liver Enzymes 568(1991)55 Human plasma lecithin:cholesterol acyltransferase. Preparation and use of CGS 20625 immobilized p-aminophenylarsenoxide as a Determination of a potential anxiolytic drug catalytic site-directed covalent ligand in enzyme (CGS 20625) in human plasma by high- purification 568(1991)69 performance liquid chromatography 568(1991)487 Purification of phospholipase C by hydrophobic interaction affinity chromatography 568(1991)85 Ciprostene Micro-quantitative determination of ciprostene in Purification and some properties of phospholipase plasma by gas chromatography—mass C from Achromobacter xylosoxidans spectrometry coupled with an antibody 568(1991)315 extraction 568(1991)460 Epidermal growth factor Cortisol Variation of hydrophobicity of human urinary Automated direct high-performance liquid epidermal growth factor 568(1991)226 chromatographic assay for estetrol, estriol, cortisone and cortisol in serum and amniotic Erythrocytes fluid 568(1991)35 Separation of living red blood cells by gravitational field-flow fractionation 568(1991)93 Cortisone Automated direct high-performance liquid Estetrol chromatographic assay for estetrol, estriol, Automated direct high-performance liquid cortisone and cortisol in serum and amniotic chromatographic assay for estetrol, estriol, fluid 568(1991)35 cortisone and cortisol in serum and amniotic fluid 568(1991)35 Cotinine Elimination of caffeine interference in high- Estriol performance liquid chromatographic Automated direct high-performance liquid determination of cotinine in human plasma chromatographic assay for estetrol, estriol, 568(1991)267 cortisone and cortisol in serum and amniotic fluid 568(1991)35 Cystine Liquid chromatographic—mass spectrometric Estrogens analysis for screening of patients with cystinuria, Automated direct high-performance liquid and identification of cystine stone 568(1991)445- chromatographic assay for estetrol, estriol, cortisone and cortisol in serum and amniotic Cytosine-f-p-arabinoside fluid 568(1991)35 Determination of cytosine-f-p-arabinoside in plasma using capillary electrophoresis Ethacrynic acid 568(1991)117 Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, N-Demethylminocycline mefenamic acid and thiosalicylic acid in plasma Identification and determination of the two and urine by high-performance liquid principal metabolites of minocycline in humans chromatography and gas chromatography—mass 568(1991)363 spectrometry 568(1991)351 516 COMPOUND INDEX 2-Ethoxy-N-|«-(2-methyl-1-propyl)- Hippuric acid 2-piperidinobenzyl|-4-carbamoylmethylbenzoic acid Determination of benzyl alcohol and its Quantitation of the new hypoglycaemic agent metabolite in plasma by reversed-phase high- AG-EE 388 ZW in human plasma by automated performance liquid chromatography high-performance liquid chromatography with 568(1991)145 electrochemical detection 568(1991)246 Hydroxyalprazolam 2-Ethylhexanoic acid New high-performance liquid chromatographic Identification of the main metabolites of 2- method for the determination of alprazolam and ethylhexanoic acid in rat urine using gas its metabolites in serum: instability of 4- chromatography—mass spectrometry hydroxyalprazolam 568(1991)253 568(1991)125 1-Hydroxy-3-aminopropyliden-1,1-biphosphonate Fatty acid methyl esters Improved determination of the bisphosphonate Analysis of human blood plasma triacylglycerols pamidronate disodium in plasma and urine by using capillary gas chromatography, silver ion pre-column derivatization with fluorescamine, thin-layer chromatographic fractionation and high-performance liquid chromatography and desorption chemical ionization mass fluorescence detection 568(1991)261 spectrometry 568(1991)1 9-Hydroxyminocycline Fatty acids Identification and determination of the two High-performance liquid chromatographic principal metabolites of minocycline in humans analysis of fatty acid compositions of platelet 568(1991)363 phospholipids as their 2-nitrophenylhydrazides 568(1991)25 5-(p-Hydroxyphenyl)-5-phenylhydantoin High-performance liquid chromatographic Flunixin method for direct separation of 5-(p- Simultaneous analysis of flunixin, naproxen, hydroxyphenyl)-5-phenylhydantoin enantiomers ethacrynic acid, indomethacin, phenylbutazone, using a chiral tris(4-methylbenzoate) column mefenamic acid and thiosalicylic acid in plasma 568(1991)157 and urine by high-performance liquid chromatography and gas chromatography—mass Hypoxanthine spectrometry 568(1991)351 Quantitation of hypoxanthine in plasma from patients with ischemic heart disease: adaption of Glucocorticoids a high-performance liquid chromatographic Automated direct high-performance liquid method 568(1991)105 chromatographic assay for estetrol, estriol, cortisone and cortisol in serum and amniotic Indomethacin fluid 568(1991)35 Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, Glutathione, oxidised mefenamic acid and thiosalicylic acid in plasma Fluorimetric determination of oxidised and and urine by high-performance liquid reduced glutathione in cells and tissues by high- chromatography and gas chromatography—mass performance liquid chromatography following spectrometry 568(1991)351 derivatization with dansyl chloride 568(1991)219 Isbufylline Glutathione, reduced Simultaneous determination of isbufylline and its Fluorimetric determination of oxidised and major metabolites in rabbit blood and urine by reduced glutathione in cells and tissues by high- reversed-phase high-performance liquid performance liquid chromatography following chromatography 568(1991)407 derivatization with dansyl chloride 568(1991)219 IsoBOSINC Glycyrrhetinic acid Photosensitizers for tumor therapy: determination Determination of glycyrrhetinic acid in human of bis(di-isobutyl octadecylsiloxy)silicon 2,3- plasma by high-performance liquid naphthalocyanine (isoBOSINC) in rat tissue and chromatography 568(1991)232 serum by high-performance liquid chromatography 568(1991)437 COMPOUND INDEX Ketamine 3-Methoxy-4-hydroxyphenylalanine Stereoselective high-performance liquid Method for measuring endogenous 3-O- chromatographic determination of the methyldopa in urine and plasma 568(1991)45 enantiomers of ketamine and norketamine in plasma 568(1991)165 2-(4-Methoxyphenyl)-5,6,7,8,9, 10-hexahydrocyclo- hepta| b|pyrazolo[3,4-d|pyridinH-)3-(on2e Ketoprofen Determination of a potential anxiolytic drug Simultaneous determination of ketoprofen (CGS 20625) in human plasma by high- enantiomers and probenecid in plasma and urine performance liquid chromatography by high-performance liquid chromatography 568(1991)487 568(1991)187 3-Methoxytyrosine Lactic acid Method for measuring endogenous 3-O- Determination of plasma lactic acid concentration methyldopa in urine and plasma 568(1991)45 and specific activity using high-performance liquid chromatography 568(1991)301 3-O-Methyldopa Method for measuring endogenous 3-O- LCAT methyldopa in urine and plasma 568(1991)45 Human plasma lecithin:cholesterol acyltransferase. Preparation and use of (5a,17«)-1’-(Methylsulphonyl)- immobilized p-aminophenylarsenoxide as a 1'-H -pregn-20-yno|3,2-c]pyrazol-17-ol catalytic site-directed covalent ligand in enzyme Determination of a novel steroidal androgen purification 568(1991)69 receptor antagonist (Win 49596) in human plasma using solid-phase extraction and high- Lecithin:cholesterol acyltransferase performance liquid chromatography with Human plasma lecithin:cholesterol ultraviolet detection 568(1991)494 acyltransferase. Preparation and use of immobilized p-aminophenylarsenoxide as a Minocycline catalytic site-directed covalent ligand in enzyme Identification and determination of the two purification 568(1991)69 principal metabolites of minocycline in humans 568(1991)363 Luteinizing hormone releasing hormone Densitometry for analysis of protein and peptide Naproxen hydrolysates: application to luteinizing hormone Simultaneous analysis of flunixin, naproxen, releasing hormone 568(1991)451 ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma Lysine and urine by high-performance liquid Liquid chromatographic—mass spectrometric chromatography and gas chromatography—mass analysis for screening of patients with cystinuria, spectrometry 568(1991)351 and identification of cystine stone 568(1991)445 Nicergoline Mefenamic acid Assay of nicergoline and three metabolites in Simultaneous analysis of flunixin, naproxen, human plasma and urine by high-performance ethacrynic acid, indomethacin, phenylbutazone, liquid chromatography—atmospheric pressure mefenamic acid and thiosalicylic acid in plasma ionization mass spectrometry 568(1991)375 and urine by high-performance liquid chromatography and gas chromatography—mass Nicotine - spectrometry 568(1991)351 Elimination of caffeine interference in high- performance liquid chromatographic 1-(4-Methanesulphonamidophenoxy)- determination of cotinine in human plasma 2-|N-(4-methanesulphonamidophenethyl)- 568(1991)267 N-methyiaminojethane Liquid—liquid extraction and high-performance liquid chromatography for the determination of a novel antidysrhythmic agent (UK-68,798) in human urine 568(1991)475